Quantcast
Last updated on April 16, 2014 at 6:16 EDT

Latest Luminex Corporation Stories

2011-10-05 14:00:00

AUSTIN, Texas, Oct. 5, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that it has joined forces with the National Marrow Donor Program - Be The Match to raise awareness of the need for additional donors to increase the chances of finding a match for the growing number of patients awaiting life-saving bone marrow transplants. Recently, more than 100 Luminex employees joined the National Marrow Donor Registry in an effort to assist patients nationwide. Luminex will...

2011-09-26 15:30:00

AUSTIN, Texas, Sept. 26, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX), today announced that it will host Planet xMAP Europe 2011, its annual European multiplexing technology symposium, September 28-29, 2011, at The Hofburg in Vienna, Austria. The event will feature scientific sessions, workshops, discussion groups, exhibitions and networking events with scientists and researchers from around the world who are performing groundbreaking work in clinical diagnostics and life...

2011-08-30 15:05:00

AUSTIN, Texas, Aug. 30, 2011 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) announced today that management will present at two upcoming investment conferences, the Morgan Stanley Global Healthcare Conference and the UBS Global Life Sciences Conference, both scheduled to take place in New York City. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Patrick J. Balthrop, president and chief executive officer, will present at the Morgan Stanley Global Healthcare...

2011-08-08 15:05:00

AUSTIN, Texas, Aug. 8, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced financial results for the second quarter ended June 30, 2011. Financial and operating highlights include the following: (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Consolidated second quarter revenue was $47.6 million, a 43% increase over the second quarter of 2010 Second quarter 2011 consumable sales of $18.4 million, a 90% increase over the second quarter of 2010...

2011-07-19 15:05:00

AUSTIN, Texas, July 19, 2011 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its xTAG Respiratory Viral Panel FAST (RVP FAST). This front line test has the potential to significantly change the way respiratory viral testing is performed and complements the company's existing respiratory portfolio. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Laboratories and...

2011-07-18 15:05:00

AUSTIN, Texas, July 18, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the second quarter of 2011 on Monday, August 8, 2011. A press release announcing the results is scheduled for release after the close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Management will hold a conference call to discuss the operating highlights and financial results for the second quarter and six months ended...

2011-06-27 15:05:00

AUSTIN, Texas, June 27, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced the completion of its acquisition of privately-held EraGen Biosciences, Inc., an innovator in molecular diagnostic testing technologies for infectious disease and genetic applications, for $34 million in cash. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Luminex expects the EraGen acquisition will add between $5 million and $7 million to 2011 consolidated revenue. On a GAAP...

2011-06-23 13:01:00

AUSTIN, Texas, June 23, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) has won two American Business Awards - Stevie Awards - Most Innovative Company of the Year (for companies with less than 2,500 employees) and Business Innovation of the Year for the MAGPIX System. A record number of nominations were submitted this year with more than 2,800 organizations from virtually all company sizes and industries. In addition to Luminex, notable Stevie Award nominees this year include...

2011-06-21 15:05:00

AUSTIN, Texas, June 21, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced a definitive agreement to acquire privately-held EraGen Biosciences, Inc., an innovator in molecular diagnostic testing technologies for infectious disease and genetic applications. Under the terms of the agreement Luminex will purchase all outstanding shares of EraGen for approximately $34 million in cash, subject to certain adjustments. The transaction is anticipated to close within the...

2011-06-08 15:30:00

AUSTIN, Texas and KOLN, Germany, June 8, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) and the Kliniken der Stadt Koln, Institute of Pathology and Institute for Hygiene today announced that Luminex's newly released xTAG® Gastrointestinal Pathogen Panel (GPP) is being used successfully as a first-line screen for patients at Kliniken der Stadt Koln suspected of having an E. coli infection. This includes the detection of hemolytic-uremic syndrome (HUS) causing...